Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 276 of 1,261
  1. US 11278573

    Methods and compositions to facilitate repair of avascular tissue

    Regenexx, LLC · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  2. US 11278529

    Methods for treating aggression associated with Alzheimer's disease

    OVID THERAPEUTICS INC. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  3. US 11278521

    GAS5 binding compounds, formulations, and uses thereof

    THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS OFFICE OF GENERAL COUNSEL—PSG IV (024) · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  4. US 11278559

    Prodrug compounds and their uses

    Ligand Pharmaceuticals Incorporated · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  5. US 11278554

    Compositions and methods for modification of biomolecules

    The Regents of the University of California · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  6. US 11278494

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  7. US 11278535

    Compounds and their methods of use

    PRAXIS PRECISION MEDICINES, INC. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  8. US 11279768

    Anti-cancer antibodies, combination therapies, and uses thereof

    PRECISION BIOLOGICS, INC. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  9. US 11279934

    Methods for treating cancer using nucleic acids targeting MDM2 or MYCN

    Phio Pharmaceuticals Corp. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  10. US 11279701

    Immunomodulators and immunomodulator conjugates

    Regents of the University of Minnesota · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  11. US 11278493

    Ophthalmic formulations providing durable ocular lubrication

    ETERNATEAR, INC. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  12. US 11279933

    Antisense oligonucleotides for the treatment of leber congenital amaurosis

    Stichting Radboud universitair medisch centrum · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  13. US 11279703

    Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereof

    APTOSE BIOSCIENCES INC. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  14. US 11278572

    Reducing CXCR4 expression and/or function to enhance engraftment of hematopoietic stem cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  15. WO 2022053708

    COMBINAISONS PHARMACEUTIQUES DESTINÉES À ÊTRE UTILISÉES POUR LE TRAITEMENT D'UN ADÉNOCARCINOME GASTRIQUE

    BASILEA PHARM INT AG [CH] · Granted Mar 17, 2022 · Expires Mar 12, 2042

    granted
  16. WO 2022053188

    NOUVELLES SÉQUENCES D'ADN ENCODANT DES ANTICORPS HUMAINS SCFV À ACTIVITÉ NEUTRALISANTE CONTRE LE SARS-CORONAVIRUS-2 ET LEURS UTILISATIONS

    ALFASIGMA SPA [IT] · Granted Mar 17, 2022 · Expires Mar 12, 2042

    granted
  17. US 11273150

    Compositions and methods for the treatment of presbyopia

    Lenz Therapeutics, Inc. · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted
  18. US 11273182

    Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease

    Takeda Pharmaceutical Company Limited · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted
  19. US 11274149

    Anti-CD100 antibodies and methods for using the same

    VACCINEX, INC. · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted
  20. US 11273226

    Hydrogel prodrug for treatment

    Viking Scientific, Inc. · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted
  21. US 11274285

    Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genome

    Precision BioSciences, Inc. · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted
  22. US 11274342

    Systems and methods for sequencing T cell receptors and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted
  23. US 11275080

    Methods for stratifying non-responders to therapies that block PD1/PDL1 axis

    The Regents of the University of California · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted
  24. US 11274318

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.